Patents by Inventor William McAvoy

William McAvoy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240144309
    Abstract: An apparatus for providing normalized hydrogen correction factor comprises: a set of sensors configured to measure telemetry data of a hydrogen production plant; a memory; a database; and a processor operatively coupled to the memory, the database, and the set of sensors. The processor is configured to: receive the telemetry data from the set of sensors; receive supplier data from the database; receive customer data from a customer; determine, using a machine learning model stored in the memory, and based on the telemetry data, the supplier data, and the customer data, a normalized hydrogen correction factor; and provide the normalized hydrogen correction factor to the customer.
    Type: Application
    Filed: October 26, 2023
    Publication date: May 2, 2024
    Inventors: Scott Gerald BORGERSON, Matthew Robert LETARTE, Nicholas McAvoy PARKER, William David LEHNER, Owen Francis BARWELL
  • Patent number: 10318436
    Abstract: A translation lookaside buffer (TLB) index valid bit is set in a first line of a virtually indexed, virtually tagged (VIVT) cache. The first line of the VIVT cache is associated with a first TLB entry which stores a virtual address to physical address translation for the first cache line. The TLB index valid bit of the first line is cleared upon determining that the translation is no longer stored in the first TLB entry. An indication of a received invalidation instruction is stored. When a context synchronization instruction is received, the first line of the VIVT cache is cleared based on the TLB index valid bit being cleared and the stored indication of the invalidate instruction.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: June 11, 2019
    Assignee: QUALCOMM Incorporated
    Inventors: William McAvoy, Brian Stempel, Spencer Williams, Robert Douglas Clancy, Michael Scott McIlvaine, Thomas Philip Speier
  • Publication number: 20190034349
    Abstract: A translation lookaside buffer (TLB) index valid bit is set in a first line of a virtually indexed, virtually tagged (VIVT) cache. The first line of the VIVT cache is associated with a first TLB entry which stores a virtual address to physical address translation for the first cache line. The TLB index valid bit of the first line is cleared upon determining that the translation is no longer stored in the first TLB entry. An indication of a received invalidation instruction is stored. When a context synchronization instruction is received, the first line of the VIVT cache is cleared based on the TLB index valid bit being cleared and the stored indication of the invalidate instruction.
    Type: Application
    Filed: July 25, 2017
    Publication date: January 31, 2019
    Inventors: William MCAVOY, Brian STEMPEL, Spencer WILLIAMS, Robert Douglas CLANCY, Michael Scott MCILVAINE, Thomas Philip SPEIER
  • Publication number: 20060088250
    Abstract: A breakout device that separates and protects individual fibers from a ribbon fiber cable. The breakout device includes a collet assembly that secures the ribbon fiber cable in the device. The collet assembly includes a base having a tapered internal bore, a collet positioned within the internal bore and a nut positioned over the base. The collet includes an aperture that receives the ribbon fiber cable and fingers that retain the ribbon fiber cable in the collet. When the nut is tightened over the base, the nut forces the collet further into the base thereby compressing the fingers axially along the cable.
    Type: Application
    Filed: October 25, 2004
    Publication date: April 27, 2006
    Inventors: Richard Pimpinella, William McAvoy, Edward Kirn
  • Patent number: 6258856
    Abstract: A method for preventing or treating pathological changes which occur in association with cataract formation in the mammalian eye by protecting lens cells against the cataractogenic effects of transforming growth factor-&bgr; (TGF&bgr;). Estrogen or an estrogenic substance can be administered to the mammal or directly to or near the eye of the mammal. The means of administration can be by a pharmaceutical composition comprising estrogen, a membranous ocular patch impregnated with estrogen or a lens or lens implant coated or impregnated with estrogen.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: July 10, 2001
    Assignee: The University of Sydney
    Inventors: Coral Gwenda Chamberlain, Johnston William McAvoy, Angela Maria Hales